APA (7th ed.) Citation

AI, C., C, V., AR, L., M, B., JS, N., & A, L. (2026). The Potential Role of SGLT2 Inhibitors in Cushing's Disease. Diabetes, obesity & metabolism, 28(8), 6550. https://doi.org/10.1111/dom.70914

Chicago Style (17th ed.) Citation

AI, Coelho, Vale C, Leite AR, Borges-Canha M, Neves JS, and Leite-Moreira A. "The Potential Role of SGLT2 Inhibitors in Cushing's Disease." Diabetes, Obesity & Metabolism 28, no. 8 (2026): 6550. https://doi.org/10.1111/dom.70914.

MLA (9th ed.) Citation

AI, Coelho, et al. "The Potential Role of SGLT2 Inhibitors in Cushing's Disease." Diabetes, Obesity & Metabolism, vol. 28, no. 8, 2026, p. 6550, https://doi.org/10.1111/dom.70914.